: What would be an adequate patient involvement in cancer clinical trials? (1) complains about the low patient and physician involvement in cancer clinical trials: Of the 1.4 million patients with a new diagnosis of cancer

Vote Up Vote Down   0 Reactions

Login to give Reaction!

What would be an adequate patient involvement in cancer clinical trials?
(1) complains about the low patient and physician involvement in cancer clinical trials:

Of the 1.4 million patients with a new diagnosis of cancer in 2008
(ACS, 2008), it is estimated that no more than 5 percent of patients enrolled
in clinical trials, with some estimates suggesting that less than 3 percent
of patients enrolled in clinical trials (reviewed by ENACCT-CCPH, 2008).
Likewise, reimbursement concerns, a lack of awareness of clinical trials, physician
or patient preference for standard therapies, excessive regulatory burdens,
and time constraints prevent many physicians from enrolling patients
in clinical trials (C-Change and Coalition of Cancer Cooperative Groups,
2006; Mansour, 1994; Somkin et al., 2005).

What would be an adequate patient involvement in cancer clinical trials? I.e., in an ideal world, what percentage of patients should be enrolled
in clinical trials?

(1) Mendelsohn, John, Harold L. Moses, and Sharyl J. Nass, eds. A National Cancer Clinical Trials System for the 21st Century:: Reinvigorating the NCI Cooperative Group Program. National Academies Press, 2010. scholar.google.com/scholar?cluster=10638934128167382656&hl=en&as_sdt=0,5

(0)

Login to post a comment!